Literature DB >> 15249304

Vaccine risk perception among reporters of autism after vaccination: vaccine adverse event reporting system 1990-2001.

Emily Jane Woo1, Robert Ball, Ann Bostrom, Sean V Shadomy, Leslie K Ball, Geoffrey Evans, Miles Braun.   

Abstract

OBJECTIVES: We investigated vaccine risk perception among reporters of autism to the Vaccine Adverse Event Reporting System (VAERS).
METHODS: We conducted structured interviews with 124 parents who reported autism and related disorders to VAERS from 1990 to 2001 and compared results with those of a published survey of parents in the general population.
RESULTS: Respondents perceived vaccine-preventable diseases as less serious than did other parents. Only 15% of respondents deemed immunization extremely important for children's health; two thirds had withheld vaccines from their children.
CONCLUSIONS: Views of parents who believe vaccines injured their children differ significantly from those of the general population regarding the benefits of immunization. Understanding the factors that shape this perspective can improve communication among vaccine providers, policymakers, and parents/patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249304      PMCID: PMC1448378          DOI: 10.2105/ajph.94.6.990

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  17 in total

1.  Inflammatory bowel disease, autism, and the measles, mumps, and rubella vaccine.

Authors:  A K Akobeng; A G Thomas
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-03       Impact factor: 2.839

2.  General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP).

Authors:  William L Atkinson; Larry K Pickering; Benjamin Schwartz; Bruce G Weniger; John K Iskander; John C Watson
Journal:  MMWR Recomm Rep       Date:  2002-02-08

3.  Evaluating risk communications: completing and correcting mental models of hazardous processes, Part II.

Authors:  A Bostrom; C J Atman; B Fischhoff; M G Morgan
Journal:  Risk Anal       Date:  1994-10       Impact factor: 4.000

4.  The Vaccine Adverse Event Reporting System (VAERS).

Authors:  R T Chen; S C Rastogi; J R Mullen; S W Hayes; S L Cochi; J A Donlon; S G Wassilak
Journal:  Vaccine       Date:  1994-05       Impact factor: 3.641

5.  Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis.

Authors:  J A Kaye; M del Mar Melero-Montes; H Jick
Journal:  BMJ       Date:  2001-02-24

6.  Do parents understand immunizations? A national telephone survey.

Authors:  B G Gellin; E W Maibach; E K Marcuse
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

7.  Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-07-09       Impact factor: 17.586

8.  Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

Authors:  Brent Taylor; Elizabeth Miller; Raghu Lingam; Nick Andrews; Andrea Simmons; Julia Stowe
Journal:  BMJ       Date:  2002-02-16

9.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

Authors:  B Taylor; E Miller; C P Farrington; M C Petropoulos; I Favot-Mayaud; J Li; P A Waight
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

10.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

View more
  7 in total

1.  Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study.

Authors:  Jennifer Richler; Rhiannon Luyster; Susan Risi; Wan-Ling Hsu; Geraldine Dawson; Raphael Bernier; Michelle Dunn; Susan Hepburn; Susan L Hyman; William M McMahon; Julie Goudie-Nice; Nancy Minshew; Sally Rogers; Marian Sigman; M Anne Spence; Wendy A Goldberg; Helen Tager-Flusberg; Fred R Volkmar; Catherine Lord
Journal:  J Autism Dev Disord       Date:  2006-04

Review 2.  Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.

Authors:  Heather Mr Ames; Claire Glenton; Simon Lewin
Journal:  Cochrane Database Syst Rev       Date:  2017-02-07

3.  Psychiatric disorders in clinical genetics I: Addressing family histories of psychiatric illness.

Authors:  Holly L Peay; Patricia McCarthy Veach; Christina G S Palmer; Beth Rosen-Sheidley; Elizabeth Gettig; Jehannine C Austin
Journal:  J Genet Couns       Date:  2007-10-26       Impact factor: 2.537

4.  Parents' perceptions of autism spectrum disorder etiology and recurrence risk and effects of their perceptions on family planning: Recommendations for genetic counselors.

Authors:  Christina G Selkirk; Patricia McCarthy Veach; Fengqin Lian; Lisa Schimmenti; Bonnie S LeRoy
Journal:  J Genet Couns       Date:  2009-06-02       Impact factor: 2.537

Review 5.  Data mining in the US using the Vaccine Adverse Event Reporting System.

Authors:  John Iskander; Vitali Pool; Weigong Zhou; Roseanne English-Bullard
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

6.  Mapping how information about childhood vaccination is communicated in two regions of Cameroon: What is done and where are the gaps?

Authors:  Heather Ames; Diangha Mabel Njang; Claire Glenton; Atle Fretheim; Jessica Kaufman; Sophie Hill; Afiong Oku; Julie Cliff; Yuri Cartier; Xavier Bosch-Capblanch; Gabriel Rada; Artur Muloliwa; Angela Oyo-Ita; Simon Lewin
Journal:  BMC Public Health       Date:  2015-12-21       Impact factor: 3.295

7.  Stakeholder perceptions of communication about vaccination in two regions of Cameroon: A qualitative case study.

Authors:  Heather Ames; Diangha Mabel Njang; Claire Glenton; Atle Fretheim; Jessica Kaufman; Sophie Hill; Afiong Oku; Julie Cliff; Yuri Cartier; Xavier Bosch-Capblanch; Gabriel Rada; Artur Manuel Muloliwa; Angela Oyo-Ita; Awah Paschal Kum; Simon Lewin
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.